skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Lower Drug Prices Aren't Worth Higher Health Risks

Drug Topics, 2018-10, Vol.162 (10), p.31-31

Copyright UBM Americas Oct 2018 ;ISSN: 0012-6616 ;EISSN: 1937-8157

Full text available

Citations Cited by
  • Title:
    Lower Drug Prices Aren't Worth Higher Health Risks
  • Author: Baney, Libby ; Menighan, Tom
  • Subjects: Counterfeiting ; Drug stores ; FDA approval ; Patient safety ; Pharmacists ; Prescription drugs ; Working groups
  • Is Part Of: Drug Topics, 2018-10, Vol.162 (10), p.31-31
  • Description: Yet, foreign sellers can already increase competition by working with authorities to export FDA-approved products to the United States via the legitimate supply chain. Whenever there is a drug shortage, public health crisis, or price spike, counterfeiters and criminals swoop in, and target patients by offering access, "deals," and even "cures." Pharmacists can play an important role in educating patients about their buying options, including ways to identify and coordinate cost-effective regimens that consider treatment plans, payer policies, and other members of the care team.
  • Publisher: Monmouth Junction: MultiMedia Healthcare Inc
  • Language: English
  • Identifier: ISSN: 0012-6616
    EISSN: 1937-8157
  • Source: Alma/SFX Local Collection
    ProQuest Central

Searching Remote Databases, Please Wait